Electra Therapeutics, Inc.

ETRA chart

Electra Therapeutics, Inc. news

• Form 4 Electra Therapeutics: ORBIMED ADVISORS LLC (Director, 10% Owner) For: 3 November

  Investing.com Nigeria · Nov 5, 8:37 PM EST

• Insider Buying: Electra Therapeutics (NASDAQ:ETRA) Director Buys $537,393.51 in Stock

  MarketBeat · Nov 5, 7:20 PM EST

• Electra Therapeutics (NASDAQ:ETRA) Director Orbimed Advisors Llc Purchases 156,091 Shares of Company Stock

  MarketBeat · Nov 5, 7:20 PM EST

• Across Nov. 3–5, OrbiMed funds bought Electra Therapeutics (ETRA) shares in 10 transactions.

  Stock Titan · Nov 5, 5:48 PM EST

• In 10 transactions, OrbiMed funds buy Electra Therapeutics (ETRA) shares.

  Stock Titan · Nov 5, 5:40 PM EST

• Electra Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference in London

  Yahoo Finance · Nov 4, 8:00 AM EST

• A London presentation from Electra Therapeutics will be webcast live Nov. 18

  Stock Titan · Nov 4, 8:00 AM EST

• Oura Shows How Shaky the IPO Market Really Is

  Yahoo Finance · Sep 30, 8:23 AM EDT

• Electra Therapeutics Announces Pricing of Upsized $350.0 Million Initial Public Offering

  Yahoo Finance · Sep 17, 8:30 PM EDT

Electra Therapeutics, Inc. key financials

No XBRL financial data is available for this company yet.

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 8-K8-K2026-09-21
• S-1S-12026-08-28

About Electra Therapeutics, Inc.

Ticker

ETRA (Nasdaq)

Industry

Biological Products, (No Diagnostic Substances)

Headquarters

South San Francisco, CA

Incorporated in

DE

Fiscal year end

December 31

SEC CIK

2088082

Frequently asked questions